Novel Amodiaquine Analogues to Treat Cervical Cancer and Microbial Infection in the Future

Shamsul Islam & Abdul Mannan · 2023-11-20

2Citations
TL;DR

Antibacterial and cytotoxic screening revealed the high potency of these compounds; analogue AS1 had a 34.3 ± 0.18 mm zone of inhibition against Pseudomonas aeruginosa and analogue AS2 had a IC50 = 4.2 μg/ml against the HeLa cell line (cervical cancer).

AI-generated by Semantic Scholar